What SG Analytics changed

• Replaced financial crime and AML case studies with new ones focused on water usage monitoring and Scope 3 carbon accounting.
• Updated the "Insights" section to feature a US SaaS industry trends report for 2026, replacing a telecom AI whitepaper.
• Added a new leadership article about scaling AI pilots for durable growth, replacing a general marketing outlook piece.
• Added specific labels "01 For Deal Teams" and "02 For Investment Teams" to their AI Studio products to clarify user targeting.
• Changed featured events from Texas-based to Florida-based capital connection conferences.

The company is moving its marketing focus away from financial crime and telecom toward environmental compliance and SaaS industry trends. This suggests they are prioritizing high-growth sectors like carbon accounting and enterprise AI scaling.

• Added "MedTech Innovation" as a new industry sub-sector under Healthcare.
• Updated the "Biopharma & Life Sciences" URL to a more specific landing page.
• Removed numbered labels ("01" and "02") and target audience headers ("For Deal Teams" and "For Investment Teams") from the AI Studios section, simplifying the visual layout.

The company is expanding its specialized healthcare offerings. By adding a dedicated MedTech section and updating its Biopharma links, they are positioning themselves to capture more specific technical markets in the life sciences sector.

• Added "01 For Deal Teams" labels to the AI Deal Studio section.
• Added "02 For Investment Teams" labels to the AI Invest Studio section.
• Modified the navigation link for "Biopharma & Life Sciences" (truncated in the latest version).

The company is refining its market positioning by clearly separating its AI tools for two distinct user groups: deal teams and investment teams. This suggests a move toward more specialized, persona-based selling in the capital markets sector.